Dr. Reagan Jarvis is a New Zealand-born medical doctor and biochemist, currently serving as the CEO and Co-founder of Anocca AB, a Swedish biotechnology company specializing in T-cell receptor-engineered T-cell (TCR-T) therapies for cancer. He earned his PhD in Biochemistry from the University of Otago and conducted postdoctoral research at the German Cancer Research Center (DKFZ) in Heidelberg .